NASDAQ: EBAY

EBAY INC

CIK 0001065088 · SIC 7389 · Miscellaneous Business Services NEC

Mega Revenue $11.1B Assets $18.0B as of Nov 20, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (JEF 10-Q) is open in full — no account needed.

10-Q Filed Oct 29, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

8-K Filed Oct 28, 2026 · Period ending Oct 28, 2026

Summary not yet generated.

Partner

Trade EBAY commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Oct 22, 2026 · Period ending Oct 20, 2026

Summary not yet generated.

10-Q Filed Aug 6, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Aug 5, 2026 · Period ending Aug 5, 2026

Summary not yet generated.

10-K Filed Feb 19, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K/A Filed May 30, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

10-Q/A Filed May 9, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-K Filed Feb 27, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Oct 29, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statement of Income

(In millions, except per share amounts)

Description Three months ended September 30, 2026 (unaudited) Three months ended September 30, 2025 Nine months ended September 30, 2026 Nine months ended September 30, 2025
Net revenues 3,206 2,820 9,429 8,135
Cost of net revenues 887 794 2,521 2,241
Gross profit 2,319 2,026 6,908 5,894
Operating expenses:
Sales and marketing 747 606 2,117 1,728
Product development 517 455 1,451 1,300
General and administrative 303 282 1,019 914
Transaction losses 122 106 393 273
Amortization of acquired intangible assets 14 6 25 18
Total operating expenses 1,703 1,455 5,005 4,233
Income from operations 616 571 1,903 1,661
Interest and other:
Gain (loss) on equity investments and warrants, net 6 (10) 10 (16)
Interest expense (64) (62) (190) (185)
Interest income and other, net 47 69 165 209
Income from continuing operations before income taxes 605 568 1,888 1,669
Income tax benefit (provision) (104) 25 (323) (210)
Income from continuing operations 501 593 1,565 1,459
Income (loss) from discontinued operations, net of income taxes (4) 35 (6) 32
Net income 497 628 1,559 1,491
Income (loss) per share - basic:
Continuing operations 1.13 1.30 3.51 3.16
Discontinued operations (0.01) 0.08 (0.01) 0.07
Net income per share basic 1.12 1.38 3.50 3.23
Income (loss) per share - diluted:
Continuing operations 1.11 1.27 3.44 3.10
Discontinued operations (0.01) 0.07 (0.01) 0.07
Net income per share diluted 1.10 1.34 3.43 3.17
Weighted-average shares:
Basic 444 456 445 461
Diluted 453 467 455 471

Condensed Consolidated Balance Sheet

(In millions, except par value)

Description September 30, 2026 (Unaudited) December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents 1,166 1,867
Short-term investments 809 1,052
Customer accounts and funds receivable 1,624 1,280
Other current assets 1,187 887
Total current assets 4,786 5,086
Long-term investments 2,171 2,767
Property and equipment, net 1,303 1,165
Goodwill 5,242 4,467
Operating lease right-of-use assets 456 428
Deferred tax assets 2,929 2,959
Other assets 1,119 565
Total assets 18,006 17,437
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Short-term debt 1,599 750
Accounts payable 339 242
Customer accounts and funds payable 1,624 1,280
Accrued expenses and other current liabilities 2,542 2,257
Income taxes payable 22 108
Total current liabilities 6,126 4,637
Operating lease liabilities 343 315
Deferred tax liabilities 1,457 1,431
Long-term debt 5,134 5,996
Other liabilities 534 575
Total liabilities 13,594 12,954
Commitments and Contingencies (Note 11)
Stockholders’ equity:
Common stock, $0.001 par value; 3,580 shares authorized; 440 and 449 shares outstanding 2 2
Additional paid-in capital 19,115 18,785
Treasury stock at cost, 1,322 and 1,307 shares (55,316) (53,807)
Retained earnings 40,426 39,296
Accumulated other comprehensive income 185 207
Total stockholders’ equity 4,412 4,483
Total liabilities and stockholders’ equity 18,006 17,437

Condensed Consolidated Statement of Cash Flows

(In millions)

Description Nine months ended September 30, 2026 (unaudited) Nine months ended September 30, 2025
Cash flows from operating activities:
Net income 1,559 1,491
Loss (income) from discontinued operations, net of income taxes 6 (32)
Adjustments:
Transaction losses 393 273
Depreciation and amortization 310 208
Stock-based compensation 511 448
Deferred income taxes 75 11
Loss (gain) on investments, warrants and other, net (40) 6
Changes in assets and liabilities, net of acquisition effects (420) (1,090)
Net cash provided by continuing operating activities 2,394 1,315
Net cash used in discontinued operating activities (27) (38)
Net cash provided by operating activities 2,367 1,277
Cash flows from investing activities:
Purchases of property and equipment (421) (309)
Purchases of investments (1,446) (6,100)
Maturities of investments 1,376 7,979
Sales of investments 745 42
Shareholder distributions from equity investments 194 227
Acquisition of Depop, net of cash acquired (1,321) —
Other (55) (96)
Net cash (used in) provided by investing activities (928) 1,743
Cash flows from financing activities:
Proceeds from issuance of common stock 64 101
Repurchases of common stock (1,473) (1,865)
Payments for taxes related to net share settlements of restricted stock units and awards (266) (208)
Payments for dividends (415) (400)
Repayment of senior notes (750) (800)
Proceeds from issuance of commercial paper 1,232 1,575
Repayment of commercial paper (493) (1,446)
Net funds receivable and payable activity 248 231
Other (12) (26)
Net cash used in financing activities (1,865) (2,838)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (17) 45
Net increase (decrease) in cash, cash equivalents and restricted cash (443) 227
Cash, cash equivalents and restricted cash at beginning of period 3,055 3,286
Cash, cash equivalents and restricted cash at end of period 2,612 3,513

Amounts as printed on the EDGAR/iXBRL face — (In millions, except per share amounts); (In millions, except par value); (In millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗